ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis
- 1 January 2004
- journal article
- Published by American Society of Hematology in Blood
- Vol. 103 (1) , 194-207
Abstract
Retinoid-related molecules (RRMs) are derivatives of retinoic acid and promising antileukemic agents with a mechanism of action different from that of other common chemotherapeutics. Here, we describe a novel chemical series designed against the RRM prototype, CD437. This includes molecules with apoptotic effects in acute promyelocytic leukemia and other myelogenous leukemia cell lines, as well as ST2065, an RRM with antagonistic properties. The most interesting apoptotic agent is ST1926, a compound more powerful than CD437 in vitro and orally active in vivo on severe combined immunodeficiency (SCID) mice that received transplants of NB4 cells. ST1926 has the same mechanism of action of CD437, as indicated by the ability to trans-activate retinoic acid receptor γ, to induce the phosphorylation of p38 and JNK, and to down-regulate the expression of many genes negatively modulated by CD437. ST1926 causes an immediate increase in the cytosolic levels of calcium that are directly related to the apoptotic potential of the RRMs considered. The intracellular calcium elevation is predominantly the result of an inhibition of the mitochondrial calcium uptake. The phenomenon is blocked by the ST2065 antagonist, the intracellular calcium chelator BAPTA (1,2 bis (2-aminophenoxy) ethane-N, N, N′,N′-tetraacetic acid tetrakis (acetoxymethyl ester), and by high concentrations of calcium blockers of the dihydropyridine type, compounds that suppress ST1926-induced apoptosis.Keywords
This publication has 35 references indexed in Scilit:
- Inhibition of IκB Kinase by a New Class of Retinoid-Related Anticancer Agents That Induce ApoptosisMolecular and Cellular Biology, 2003
- Elucidation of Molecular Events Mediating Induction of Apoptosis by Synthetic Retinoids Using a CD437-resistant Ovarian Carcinoma Cell LineJournal of Biological Chemistry, 2002
- Induction of apoptosis of human B-CLL and ALL cells by a novel retinoid and its nonretinoidal analogBlood, 2002
- Down-regulation of the Phosphatidylinositol 3-Kinase/Akt Pathway Is Involved in Retinoic Acid-induced Phosphorylation, Degradation, and Transcriptional Activity of Retinoic Acid Receptor γ2Journal of Biological Chemistry, 2002
- Retinoic acid receptor-independent mechanism of apoptosis of melanoma cells by the retinoid CD437 (AHPN)Cell Death & Differentiation, 2001
- Evidence of a lysosomal pathway for apoptosis induced by the synthetic retinoid CD437 in human leukemia HL-60 cellsCell Death & Differentiation, 2001
- Activation of the p38 and JNK/SAPK Mitogen-Activated Protein Kinase Pathways during Apoptosis Is Mediated by a Novel RetinoidExperimental Cell Research, 1999
- Effects of Synthetic Retinoids and Retinoic Acid Isomers on the Expression of Alkaline Phosphatase in F9 Teratocarcinoma CellsBiochemical and Biophysical Research Communications, 1993
- 2,5‐Di(tert‐butyl)‐1,4‐benzohydroquinone — a novel inhibitor of liver microsomal Ca2+ sequestrationFEBS Letters, 1987
- The Calcium‐Induced and Sodium‐Induced Effluxes of Calcium from Heart MitochondriaEuropean Journal of Biochemistry, 1977